Security Advisory: Global Phishing Campaign Targeting the COVID-19 Vaccine Cold Chain  

December 28, 2020

At the onset of the COVID-19 pandemic, IBM Security X-Force created a threat intelligence task force dedicated to tracking down COVID-19 cyber threats against organizations that are keeping the vaccine supply chain moving.

The cold chain is a component of the vaccine supply chain that ensures the safe preservation of vaccines in temperature-controlled environments during their storage and transportation.

The adversary impersonated a business executive from Haier Biomedical, a credible and legitimate member company of the COVID-19 vaccine supply chain and qualified supplier. The company is purportedly the world’s only complete cold chain provider.

Disguised as this employee, the adversary sent phishing emails to organizations believed to be providers of material support to meet transportation needs within the COVID-19 cold chain. We believe that the purpose of this COVID-19 phishing campaign may have been to harvest credentials, possibly to gain future unauthorized access to corporate networks and sensitive information relating to COVID-19 vaccine distribution.

Read More >

Related posts

A 2018 report by McAfee and the Center for Strategic and International Studies estimates that cybercrime costs the world almost $600 billion annually, or 0.8% of global GDP, which is up 35% from an estimated $445 billion in 2014. New technologies have made attackers more efficient and effective, and the

Read More

In a welcome development, both New Jersey and Pennsylvania have announced that they will conform to the federal government's tax treatment in allowing Paycheck Protection Program (PPP) loans to be tax exempt at the state level and allowing recipients to deduct business expenses that were paid with the tax-exempt loan

Read More

Description Hear from our experts, Alisha and John, as they provide updates for business owners preparing to file for forgiveness on the first PPP what's going on, what are some of the challenges that our clients are facing? Are there delays? What's causing the delays? DISCLAIMER:  All information shared on this

Read More

Copyright 2021 - Mazars - United States